RD

Ripu Daman Singh

Active Director Director DIN 06469093
DIN 06469093 First appointment Jan 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2013
Shareholding value •••• Premium profile

About Ripu Daman Singh

Data last updated:

Ripu Daman Singh is a Director at P R A B Pharmaceutical Private Limited (since 2013). The company operates in Pharma. P R A B Pharmaceutical Private Limited reported revenue of ₹16.5 Lakh (FY 2019).

DIN 06469093
Primary Designation Director
Industry Pharma
First Appointment 17 Jan 2013
Oldest Company Age 13 yrs
Largest company P R A B Pharmaceutical Private Limited · ₹16.5 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jan 20132013₹16.5 Lakh (FY 2019)Active

Board colleagues of Ripu Daman Singh

Directorship timeline

Open interactive timeline →
P R A B Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Ripu Daman Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ripu Daman Singh

Ripu Daman Singh currently holds 1 directorship: P R A B Pharmaceutical Private Limited (Director, since 17 Jan 2013, revenue ₹16.5 Lakh (FY 2019)).

Ripu Daman Singh was first appointed on 17 Jan 2013 as Director at P R A B Pharmaceutical Private Limited.

The current boards of Ripu Daman Singh's companies include Amit Goyal (P R A B Pharmaceutical Private Limited), Brij Kishor (P R A B Pharmaceutical Private Limited), Prem Verma (P R A B Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available